A New Tool for Assessing Fatigue in Individuals With Advanced Cancer
This study has been completed.
Information provided by (Responsible Party):
Karin Olson, University of Alberta
First received: January 26, 2007
Last updated: November 29, 2011
Last verified: November 2011
Fatigue is a common problem in advanced cancer and palliative care. The development of tools to measure fatigue, however, has been slowed by their inability to distinguish between fatigue and other related symptoms, such as tiredness. Our work suggests that these distinctions are important because they serve as markers for stressors associated with advancing disease. We have developed a tool that we believe will distinguish between these two states as well as exhaustion. In this study we will conduct some initial tests of this tool in preparation for its use as an outcome indicator in future studies.
||Time Perspective: Prospective
||Development of a Rapid Assessment Tool for Fatigue in Palliative Care
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||October 2007 (Final data collection date for primary outcome measure)
Based on a series of qualitative studies, our group is developing a new rapid fatigue assessment screening tool (rFAST) for use with individuals who have advanced cancer and are receiving care in either an active treatment or palliative setting.
- The three tools (tiredness, fatigue, and exhaustion) in the rFAST are each defined by the same six dimensions: decline in stamina, decline in cognition, decline in sleep quality, diminished social network, and increased emotional reactivity
- The five subscales of the tiredness, fatigue, and exhaustion scales are internally consistent.
- Tiredness, fatigue, and exhaustion are distinct states that are manifested by unique patterns of scores on their 6 subscales
- The mean POMS-Vsf scores of individuals who meet the definition of fatigue will be lower than the mean POMS-Vsf scores of individuals who meet the definition of tiredness and higher than the mean POMS-Vsf scores of individuals who meet the definition of exhaustion.
- To examine the factor structure of the tiredness, fatigue, and exhaustion scales of the rFAST.
- To examine the internal consistency of the 5 subscales within the tired, fatigue, and exhaustion scales.
- To compare actual rFAST scale scores to hypothesized scale profiles for tiredness, fatigue, and exhaustion.
|Ages Eligible for Study:
||18 Years and older (Adult, Senior)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
Individuals with advanced cancer
- Patients with advanced cancer currently receiving treatment for either hematologic or lung cancer at the Jewish General Hospital in Montreal, or patients with advanced cancer currently receiving care through the Alberta Cancer Board (Cross Cancer Institute or Tom Baker Cancer Centre), or the palliative care programs associated with the regional health authority in Edmonton, Alberta who are at least 18 years old, able to read and write English, have a Folstein Mini Mental Status Exam score of at least 22.
- Patients unable to give informed consent in English.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00428675
|Faculty of Nursing, University of Alberta
|Edmonton, Alberta, Canada, T6G 2T4 |
||Karin L Olson, Ph.D.
||University of Alberta
||Karin Olson, Professor, Nursing, University of Alberta
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 26, 2007
||November 29, 2011
Keywords provided by Karin Olson, University of Alberta:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on June 23, 2017
Signs and Symptoms